These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31257939)

  • 81. HIV prevention and drug treatment services for drug misusers: a national study of community pharmacists' attitudes and their involvement in service specific training.
    Sheridan J; Strang J; Taylor C; Barber N
    Addiction; 1997 Dec; 92(12):1737-48. PubMed ID: 9581006
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Pharmacist work stress and learning from quality related events.
    Boyle TA; Bishop A; Morrison B; Murphy A; Barker J; Ashcroft DM; Phipps D; Mahaffey T; MacKinnon NJ
    Res Social Adm Pharm; 2016; 12(5):772-83. PubMed ID: 26604005
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Exploration of pharmacist comfort with harm reduction behaviors: Cross-sectional latent class analysis.
    Agley J; Meyerson BE; Eldridge LA; Crosby RA; Bentele KG; Jun M; Vadiei N; Kennedy A; Anderson K
    J Am Pharm Assoc (2003); 2022; 62(2):432-440. PubMed ID: 34742654
    [TBL] [Abstract][Full Text] [Related]  

  • 84. How involvement of community pharmacies improves accessibility to and awareness about flu vaccination? - An example from Estonia.
    Sepp K; Kukk C; Cavaco A; Volmer D
    Expert Rev Vaccines; 2020 Oct; 19(10):983-990. PubMed ID: 32940097
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The influence of pharmacy and pharmacist characteristics on the secondary prevention of cardiovascular disease.
    Puspitasari HP; Aslani P; Krass I
    Int J Clin Pharm; 2015 Oct; 37(5):834-43. PubMed ID: 25964140
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Evaluating community pharmacists' HIV testing knowledge: A cross-sectional survey.
    Pineda LJ; Mercier RC; Dilworth T; Iandiorio M; Rankin S; Jakeman B
    J Am Pharm Assoc (2003); 2015; 55(4):424-8. PubMed ID: 26161484
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Hepatitis C Virus Screening of High-Risk Patients in a Canadian Emergency Department.
    Ragan K; Pandya A; Holotnak T; Koger K; Collins N; Swain MG
    Can J Gastroenterol Hepatol; 2020; 2020():5258289. PubMed ID: 32211349
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Perceived preparedness for full-scope pharmacist services among recent Doctor of Pharmacy graduates from Ontario schools of pharmacy.
    Waite NM; McCarthy L; Milne E; Hillier C; Houle SKD; Dolovich L
    J Am Pharm Assoc (2003); 2018; 58(6):630-637. PubMed ID: 30077565
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Pharmacist Segments Identified from 2009, 2014, and 2019 National Pharmacist Workforce Surveys: Implications for Pharmacy Organizations and Personnel.
    Schommer J; Doucette W; Witry M; Arya V; Bakken B; Gaither C; Kreling D; Mott D
    Pharmacy (Basel); 2020 Mar; 8(2):. PubMed ID: 32224863
    [No Abstract]   [Full Text] [Related]  

  • 90. Characteristics of unmet demand for pharmacists: a survey of rural community pharmacies in Wisconsin.
    Gadkari AS; Mott DA; Kreling DH; Bonnarens JK
    J Am Pharm Assoc (2003); 2008; 48(5):598-609. PubMed ID: 18826899
    [TBL] [Abstract][Full Text] [Related]  

  • 91. DOT-C: A cluster randomised feasibility trial evaluating directly observed anti-HCV therapy in a population receiving opioid substitute therapy from community pharmacy.
    Radley A; Tait J; Dillon JF
    Int J Drug Policy; 2017 Sep; 47():126-136. PubMed ID: 28647161
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Assessing the proportion of patients with hepatitis C treated before and after initiation of an ambulatory pharmacist-led hepatitis C program: A retrospective analysis.
    Ortiz J; Rasch M
    J Am Pharm Assoc (2003); 2023; 63(1):440-446. PubMed ID: 36272941
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Community pharmacist perspectives on HIV/AIDS and interventions for injection drug users in Canada.
    Myers T; Cockerill R; Worthington C; Millson M; Rankin J
    AIDS Care; 1998 Dec; 10(6):689-700. PubMed ID: 9924524
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Alaska pharmacists: First responders to the pandemic in the last frontier.
    Paul AK; Bogart T; Schaber AR; Cutchins DC; Robinson RF
    J Am Pharm Assoc (2003); 2021; 61(1):e35-e38. PubMed ID: 33036935
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Performance of premarket rapid hepatitis C virus antibody assays in 4 national human immunodeficiency virus behavioral surveillance system sites.
    Smith BD; Teshale E; Jewett A; Weinbaum CM; Neaigus A; Hagan H; Jenness SM; Melville SK; Burt R; Thiede H; Al-Tayyib A; Pannala PR; Miles IW; Oster AM; Smith A; Finlayson T; Bowles KE; Dinenno EA
    Clin Infect Dis; 2011 Oct; 53(8):780-6. PubMed ID: 21921221
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Assessment of community pharmacists' communication and comfort levels when interacting with Deaf and hard of hearing patients.
    Chong EY; Jacob SA; Ramadas A; Goh PH; Palanisamy UD
    Pharm Pract (Granada); 2021; 19(2):2274. PubMed ID: 34221194
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Hepatitis C virus screening in community pharmacies: results on feasibility from a Swiss pilot.
    Stämpfli D; Imfeld-Isenegger TL; Hersberger KE; Messerli M
    BMC Infect Dis; 2023 Jun; 23(1):384. PubMed ID: 37286975
    [TBL] [Abstract][Full Text] [Related]  

  • 98. A Cross-Sectional Survey on the Post-Pandemic Acceptability of Pharmacist-Delivered Telehealth Services Among HCV-HIV Patients.
    Mayaka RK; Awuonda MK; Ettienne E; Daftary M; Wingate L; Unonu J
    Inquiry; 2023; 60():469580231171338. PubMed ID: 37232384
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Assessing intradisciplinary pharmacy communication related to transitions of care.
    Warunek LN; Gruver B; Bartko L; Blair J
    Explor Res Clin Soc Pharm; 2024 Jun; 14():100438. PubMed ID: 38646470
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Leveraging Expertise from Community Resources to Improve the Role of the Pharmacist in HIV Testing and Counseling.
    Diaz-Cruz ES; Thompson S; Hawkins M; Zengotita-Borges R; Jefferson K
    Innov Pharm; 2021; 12(4):. PubMed ID: 36033120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.